• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

fMRI gauges procedure to reduce PTSD pain
Could vagus nerve stimulation help ease pain from post-traumatic stress disorder...Read more on AuntMinnie.comRelated Reading: fMRI helps finds brain biomarkers linked to severe PTSD MRI could play role in curing digestive disorders fMRI shows dehydration's effect on the brain fMRI shows how game therapy 'rewires' ADHD brains fMRI shows how mindfulness training can help veterans
Source: AuntMinnie.com Headlines - February 13, 2019 Category: Radiology Source Type: news

NeuroSigma wins CE Mark for eTNS ADHD system
NeuroSigma Systems said today it won CE Mark approval in the European Union for its Monarch eTNS system to treat attention-deficit/hyperactivity disorder in adults and children 7 and older. Los Angeles-based NeuroSigma said it is the 1st and only non-drug treatment for ADHD approved in the European Union. “ADHD is estimated to affect up to 9.5% of school age children and 4.4% of adults, and many people have concerns about using stimulant medications.  In research conducted at the University of California, Los Angeles, eTNS was well accepted by children and their parents, and produced significant improvements in th...
Source: Mass Device - November 17, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Neurological Regulatory/Compliance NeuroSigma Inc Source Type: news

Epilepsy device developer NeuroSigma withdraws IPO
UCLA-spun out NeuroSigma Systems withdrew its plans for an initial public offering that could have brought the company as much as $50 million for its noninvasive system to treat drug-resistant epilepsy. NeuroSigma is developing the Monarch eTNS system, which delivers mild electrical signals through a forehead patch to stimulate branches of the trigeminal nerve. The Los Angeles-based company is marketing the device as an alternative to vagus nerve stimulation and deep-brain stimulation, both of which require surgical implants. NeuroSigma is also developing a subcutaneous, implantable version of the system. Last August Neur...
Source: Mass Device - September 28, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Initial Public Offering (IPO) Neurological NeuroSigma Source Type: news